Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Receptor-type tyrosine-protein kinase FLT3 [572-603] |
---|
Ligand | BDBM621125 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Kinase Binding Assay |
---|
Kd | 0.910±n/a nM |
---|
Citation | HOYT, SB; THOMAS, CJ; FINOCCHIO, CJ; STARCZYNOWSKI, DT; TAWA, GJ; GRACIA MALDONADO, G; ROSEBAUM, JS MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US Patent US20230303563 Publication Date 9/28/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Receptor-type tyrosine-protein kinase FLT3 [572-603] |
---|
Name: | Receptor-type tyrosine-protein kinase FLT3 [572-603] |
Synonyms: | juxtamembrane domain of FLT3 (FLT3-JM-PMs) | The autoinhibitory JM domain of FLT3 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 4028.26 |
Organism: | Homo sapiens (Human) |
Description: | P36888[572-603] |
Residue: | 32 |
Sequence: | YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW
|
|
|
BDBM621125 |
---|
n/a |
---|
Name | BDBM621125 |
Synonyms: | (R)-N-(6-(6- (difluoromethyl)imidazo[1,2- a]pyridin-3-yl)pyridin-2-yl)-5- azaspiro[2.4]heptan-7-amine | US20230303563, Compound 172 |
Type | Small organic molecule |
Emp. Form. | C19H19F2N5 |
Mol. Mass. | 355.3845 |
SMILES | FC(F)c1ccc2ncc(-c3cccc(N[C@H]4CNCC44CC4)n3)n2c1 |r| |
Structure |
|